Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus
Thrombosis Research, 10/01/2010Mortensen SB et al.
Diabetic patients with coronary artery disease had significantly higher levels of both platelet aggregation and activation compared to non–diabetic patients with coronary artery disease despite treatment with the same dosage of aspirin. These findings may partly explain the reduced cardiovascular protection from aspirin in diabetic patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.